Business Wire

ADVA launches sustainable supplier program to tackle CO 2 emissions

Share

ADVA (FSE: ADV) today announced the launch of its sustainable supplier program as part of its ongoing commitment to radically reduce greenhouse gas emissions. The initiative extends ADVA’s holistic sustainability strategy upstream in its supply chain and is a key step towards the company’s production processes becoming completely carbon neutral. Launched in cooperation with ADVA’s finance platform partner Traxpay, the program involves ADVA offering financial incentives to its suppliers who meet strict criteria for minimizing environmental impact. The scheme also strengthens ADVA’s supply chain at a time of unprecedented logistical challenges, including material shortages and the global semiconductor crisis.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211119005111/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Steven Williams, Director, Treasury and Investor Relations, ADVA (Photo: Business Wire)

“The sustainable supplier program is another milestone in expanding our environmental, social and governance (ESG) activities and ensuring environmentally friendly supply chain management. Everyone needs to play their part to fight climate change and so we’re rewarding our suppliers who share our dedication to taking urgent action now,” said Klaus Grobe, director, global sustainability, ADVA. “Our commitment to setting and meeting strict emissions targets has made ADVA one of the world’s leading systems vendors when it comes to sustainability. Now we’re also incentivizing our suppliers to prioritize the future and meet the highest standards in the industry for carbon reduction.”

ADVA’s sustainable supplier program is part of its commitments based on the most ambitious goals of the COP26 Glasgow Climate Pact: limiting global temperature increase to 1.5°C above pre-industrial levels. The company was one of the first telecommunication technology suppliers to have targets approved by the Science Based Targets Initiative (SBTi) and the criteria for its new supplier program are in line with ADVA’s own sustainability goals. These are in turn checked by customers, including regular assessments with the TIA Assessor tool and EcoVadis ratings. To evaluate suppliers’ sustainability activities ADVA will leverage IntegrityNext software. ADVA will also work with its partner NORD/LB, which will ensure financial security by providing additional liquidity for the program.

“With our new initiative, we’re empowering our suppliers to make a significant difference. Our sustainable supplier program motivates them to reduce the environmental impact of their business and helps them achieve sustainable success. It will also make a decisive contribution to maintaining robust supply chains, especially in the current era of global material shortages,” commented Steven Williams, director, treasury and investor relations, ADVA. “Since 2017, ADVA has held a Gold TIA rating and last year we achieved our first EcoVadis Platinum rating. Now, we’re widening the scope of our efforts. Alongside our partners Traxpay and NORD/LB, we’re rewarding sustainable suppliers for their ESG activities and encouraging other companies to help tackle this most urgent challenge.”

About ADVA

ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.

Published by:

ADVA Optical Networking SE, Munich, Germany
www.adva.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com

For investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

IonQ Unanimously Appoints Peter Chapman as Next Chairman of the Board of Directors26.4.2024 13:30:00 CEST | Press release

IonQ (NYSE: IONQ), a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ’s upcoming Annual General Meeting on June 5, 2024. Both appointments were disclosed in a proxy statement issued on April 25, 2024. Peter Chapman has also been nominated for re-election as a Class III director at the meeting, and his chairmanship will take effect assuming he is re-elected. “Last quarter we were delighted to have appointed Robert Cardillo and Bill Scannell to our Board of Directors. In addition, the Board unanimously appointed Peter Chapman to serve as its next Chairman following the annual meeting given his half-decade worth of contributions to IonQ and his strong progress transitioning IonQ from an academic to a commercial company,” said Niccolo de Masi, Chairman of the Nominating & Corporate Governance Committee of IonQ’s Board. “Unde

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye